H1N1 flu jab linked to small risk of nervous disorder

Vaccination in the United States against H1N1 "swine" flu, which swept the world in 2009-10, carried a small but tolerable risk of Guillain-Barre syndrome, a disorder that can cause muscle weakness or temporary paralysis, a study published on Wednesday said.

US researchers scanned a database of side effects from the campaign in which 23 million Americans were inoculated with a so-called monovalent inactivated vaccine against H1N1.

They recorded 77 cases of Guillain-Barre that occurred within three months of a vaccination.

Compared to normal times, incidence amounted to about 1.6 extra cases per one million people vaccinated, which means the benefit of the jab "greatly outweighed" the risks, they said.

The modest incidence was probably similar to cases of Guillain-Barre that arise from annual vaccination for "seasonal" flu, they said.

The study, published by The Lancet, was carried out by the National Vaccine Program Office in Washington.

It said about 61 million cases of H1N1 were recorded in the United States during the , leading to 274,000 and 12,470 deaths.

Research published last month estimated that vaccination prevented between 700,000 and 1.5 million cases of flu in the United States, between 4,000 and 10,000 admissions and up to 500 deaths.

The American programme did not use Pandemrix, a that uses a booster to prime the immune system against the H1N1 virus.

According to investigations in Finland, Sweden and England, Pandemrix increased the risk of narcolepsy, a disorder that causes extreme drowsiness, among teenagers and young people, although the extent of the problem is unclear.

More than a fifth of the world's population was infected with the H1N1 virus in the 2009-2010 pandemic, according to estimates published in January.

Health watchdogs anxiously monitor mutations of the , fearing the emergence of new strains against which humans would have no resistance.

Tens of millions of people were killed in the 1918-19 pandemic of so-called Spanish flu.

But the H1N1 type, while very contagious, was about as lethal as ordinary flu.

Guillain-Barre occurs when the body starts to attack nerves involved in movement and sometimes respiration and other functions.

It leapt into the headlines in 1976, when a campaign to vaccinate the US population against a new flu strain was stalled by contentions—later contested—that the jab led to an increase in cases of this otherwise rare auto-immune disorder.

add to favorites email to friend print save as pdf

Related Stories

Two die of A(H1N1) swine flu in Mexico: official

Jan 22, 2012

An outbreak of A(H1N1) swine flu claimed the lives of two people -- 19 and 21 years old -- in Mexico's capital in the first weeks of the year, health authorities said Saturday.

Recommended for you

Sierra Leone streets deserted as shutdown begins

48 minutes ago

Sierra Leone's normally chaotic capital was transformed on Friday as residents were confined to their homes for the start of a three-day lockdown aimed at halting the deadly Ebola epidemic.

Sierra Leone launches controversial Ebola shutdown

2 hours ago

Sierra Leone on Friday launched a controversial three-day shutdown to contain the deadly spread of the Ebola virus, as the UN Security Council declared the deadly outbreak a threat to world peace.

Cooling of dialysis fluids protects against brain damage

15 hours ago

While dialysis can cause blood pressure changes that damage the brain, cooling dialysis fluids can protect against such effects. The findings come from a study appearing in an upcoming issue of the Journal of the American So ...

Two Ebola vaccines to be tested in Switzerland

15 hours ago

Clinical trials of two experimental vaccines against the deadly Ebola virus are due to begin soon in Switzerland, the country's Tropical and Public Health Institute said on Thursday.

User comments